Clinical Trial Update: Oral Clofarabine Study in Patients With Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial of oral clofarabine in patients with myelodysplastic syndrome and chronic myelomonocytic leukemia has completed; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• Clofarabine (clofarabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2015-09-18